2017-12-04 22:43:27 UTC

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Register for our free webinar to gain insight into the evidence of currently available biosimilars for IBD and approaches to discussing biosimilars with patients. Register now.

This activity is a collaboration of the AGA Institute and the Crohn's & Colitis Foundation. Supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.

More on Biosimilars

Advent of Biosimilar Products in US GI Practice
Get a better understanding of how biosimilars are utilized in U.S. gastroenterology practices. 

Considerations in Use of Biosimilars for GI Disorders
An overview of the safety and efficacy of biosimilar products. Biosimilar pricing and the impact of payor decisions on clinical GI practice are also explored.

More on Biosimilars

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Talking With Your IBD Patients About Biosimilars

Dec. 20, 2017

In this on-demand video series, Sophie Balzora, MD, will provide an overview of the concerns patients may have about biosimilar therapies, and how best to address those concerns.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.